{"id":"NCT04871711","sponsor":"LEO Pharma","briefTitle":"Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema","officialTitle":"A Phase 3 Clinical Trial to Confirm Efficacy and Evaluate Safety of Twice-daily Delgocitinib Cream 20 mg/g Compared With Cream Vehicle for a 16-week Treatment Period in Adult Subjects With Moderate to Severe Chronic Hand Eczema (DELTA 1)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-05-10","primaryCompletion":"2022-10-31","completion":"2022-10-31","firstPosted":"2021-05-04","resultsPosted":"2024-09-23","lastUpdate":"2025-04-08"},"enrollment":487,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hand Eczema"],"interventions":[{"type":"DRUG","name":"Delgocitinib cream","otherNames":["LEO 124249 cream"]},{"type":"DRUG","name":"Cream vehicle","otherNames":[]}],"arms":[{"label":"Delgocitinib cream 20 mg/g","type":"EXPERIMENTAL"},{"label":"Cream vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"This was a 16-week study in adult participants with chronic hand eczema (CHE). \\> The participants visited the clinic regularly to have the study doctor assess their CHE and to answer questions about itch, pain, CHE symptoms, and quality of life.\n\n\\> The purpose was to assess how delgocitinib cream works to treat CHE when compared to a placebo cream with no active substance.","primaryOutcome":{"measure":"Number of Participants With IGA-CHE TS at Week 16","timeFrame":"16 weeks","effectByArm":[{"arm":"Delgocitinib Cream 20 mg/g","deltaMin":64,"sd":null},{"arm":"Cream Vehicle","deltaMin":16,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.006"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":17},"locations":{"siteCount":54,"countries":["Canada","France","Germany","Italy","Poland","United Kingdom"]},"refs":{"pmids":["39033766","38507100","38485862"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":325},"commonTop":["COVID-19","Nasopharyngitis","Headache","Allergy to metals","Dermatitis contact"]}}